Lucio Iannone
Direktor/Vorstandsmitglied bei Immunitas Therapeutics, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Jürgen Eckhardt | M | 57 |
Khloris Biosciences, Inc.
 Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA.
Leaps by Bayer
 Leaps by Bayer Investment ManagersFinance Leaps by Bayer is venture investment unit of Bayer AG (Xetra: BAYN) founded in 2015. The firm is headquartered in Leverkusen, Germany.
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA.
Vesigen, Inc.
 Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA.
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | 6 Jahre |
| Amir Nashat | M | 51 |
Paratus Sciences Corp.
 Paratus Sciences Corp. BiotechnologyHealth Technology Paratus Sciences Corp. is an American company that focuses on unlocking the secrets of bat biology. The company's main goal is to elucidate novel insights and identify new therapeutic targets. The company was founded by Thomas Zwaka, Richard Young, Paul Matsudaira. The CEO is Amir H. Nashat.
Kojin Therapeutics, Inc.
 Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | - |
| Stefan Lohmer | M | - |
Axxam SpA
 Axxam SpA Miscellaneous Commercial ServicesCommercial Services Axxam SpA provides pharmaceuticals services. The firm specializes in molecular biology, electrophysiology, cellular and biochemical systems. The company was founded by Stefan Lohmer and Alessandro Sidoli in November 2001 and is headquartered in Bresso, Italy. | 23 Jahre |
| Paul Sekhri | M | 66 |
eGenesis, Inc.
eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | 5 Jahre |
| Lara Sullivan | M | 51 | 5 Jahre | |
| Steven Gillis | M | 71 |
Mozart Therapeutics, Inc.
 Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning.
eGenesis, Inc.
eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | - |
| Harvey J. Berger | M | 74 |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | - |
| Lynne Bui | M | 53 |
Khloris Biosciences, Inc.
Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA. | - |
| Alessandro Sidoli | M | 65 |
Axxam SpA
Axxam SpA Miscellaneous Commercial ServicesCommercial Services Axxam SpA provides pharmaceuticals services. The firm specializes in molecular biology, electrophysiology, cellular and biochemical systems. The company was founded by Stefan Lohmer and Alessandro Sidoli in November 2001 and is headquartered in Bresso, Italy. | 23 Jahre |
| Lea Hachigian | M | - |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | - |
| Julie Sunderland | F | 51 |
eGenesis, Inc.
eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | 7 Jahre |
| Jak Knowles | M | - |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | 5 Jahre |
| Theresa Heah | M | 46 |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Paratus Sciences Corp. is an American company that focuses on unlocking the secrets of bat biology. The company's main goal is to elucidate novel insights and identify new therapeutic targets. The company was founded by Thomas Zwaka, Richard Young, Paul Matsudaira. The CEO is Amir H. Nashat. | - |
| W. Smith | M | 68 |
eGenesis, Inc.
eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | 3 Jahre |
| Pamela Connealy | F | 62 | 3 Jahre | |
| Amanda Wagner | F | - |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | - |
| Julie Yang | M | - |
Leaps By Bayer /US/
Khloris Biosciences, Inc.
Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA. | 1 Jahre |
| Joseph C. Wu | M | - |
Khloris Biosciences, Inc.
Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA. | - |
| Katie Fanning | F | - |
Mozart Therapeutics, Inc.
Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | - |
| Jan Pinkas | M | - | 3 Jahre | |
| Thomas Civik | M | 55 | 3 Jahre | |
| Richard Young | M | - |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Paratus Sciences Corp. is an American company that focuses on unlocking the secrets of bat biology. The company's main goal is to elucidate novel insights and identify new therapeutic targets. The company was founded by Thomas Zwaka, Richard Young, Paul Matsudaira. The CEO is Amir H. Nashat. | - |
| Stuart Schreiber | M | - |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | - |
| Christoph Westphal | M | 56 |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | - |
| Freda Lewis-Hall | M | 69 | 3 Jahre | |
| Nagesh Mahanthappa | M | 59 |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | - |
| Darren Cline | M | 59 | 3 Jahre | |
| Sarah Schlesinger | M | 64 |
eGenesis, Inc.
eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | - |
| Paulash Mohsen | M | - |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | 2 Jahre |
| Paimun Amini | M | - |
Leaps By Bayer /US/
| 5 Jahre |
| Lee Cooper | M | - |
Leaps By Bayer /US/
| 4 Jahre |
| Ingo Klöckner | M | - |
Leaps by Bayer
Leaps by Bayer Investment ManagersFinance Leaps by Bayer is venture investment unit of Bayer AG (Xetra: BAYN) founded in 2015. The firm is headquartered in Leverkusen, Germany. | 7 Jahre |
| Pamela Sisson | M | - |
Leaps By Bayer /US/
| 4 Jahre |
| Ryan D. Teksten | M | - |
Leaps By Bayer /US/
| 4 Jahre |
| Julie Gilmore | M | - |
Mozart Therapeutics, Inc.
Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | - |
| Kathleen Fanning | F | - |
eGenesis, Inc.
eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | - |
| Harvey Lodish | M | - |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Paratus Sciences Corp. is an American company that focuses on unlocking the secrets of bat biology. The company's main goal is to elucidate novel insights and identify new therapeutic targets. The company was founded by Thomas Zwaka, Richard Young, Paul Matsudaira. The CEO is Amir H. Nashat. | - |
| Olivia Zetter | F | - |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Paratus Sciences Corp. is an American company that focuses on unlocking the secrets of bat biology. The company's main goal is to elucidate novel insights and identify new therapeutic targets. The company was founded by Thomas Zwaka, Richard Young, Paul Matsudaira. The CEO is Amir H. Nashat. | - |
| Jan Beck | M | - |
Mozart Therapeutics, Inc.
Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | 2 Jahre |
| Marie-Claire Peakman | F | - |
Mozart Therapeutics, Inc.
Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | 1 Jahre |
| K. Christopher Garcia | M | - |
Mozart Therapeutics, Inc.
Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | - |
| Jitendra Wadhane | M | 44 | 3 Jahre | |
| Jasmina Marjanovic | F | - |
Mozart Therapeutics, Inc.
Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | 1 Jahre |
| Stephen Bruso | M | - |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | 4 Jahre |
| Al L. Wiegman | M | - |
eGenesis, Inc.
eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | - |
| Peter Dudek | M | - |
Mozart Therapeutics, Inc.
Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | 4 Jahre |
| Lynette Herscha | F | 52 |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | 2 Jahre |
| Henrijette Richter | M | 53 |
Mozart Therapeutics, Inc.
Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | - |
| Dieter Weinand | M | 63 |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | 3 Jahre |
| Laura Brass | M | - |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | - |
| Michael S. Curtis | M | - |
eGenesis, Inc.
eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | 2 Jahre |
| Geeta S. Vemuri | M | - |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | - |
| Giorgio Chirivi | M | 63 |
Axxam SpA
Axxam SpA Miscellaneous Commercial ServicesCommercial Services Axxam SpA provides pharmaceuticals services. The firm specializes in molecular biology, electrophysiology, cellular and biochemical systems. The company was founded by Stefan Lohmer and Alessandro Sidoli in November 2001 and is headquartered in Bresso, Italy. | 19 Jahre |
| Lok Chung Chan | M | 73 |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | 4 Jahre |
| Mark Pruzanski | M | 56 |
eGenesis, Inc.
eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | - |
| Wen Kai Xiang | M | - |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | - |
| Charles Kunsch | M | - |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | 3 Jahre |
| Oleg Nodelman | M | 47 |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Paratus Sciences Corp. is an American company that focuses on unlocking the secrets of bat biology. The company's main goal is to elucidate novel insights and identify new therapeutic targets. The company was founded by Thomas Zwaka, Richard Young, Paul Matsudaira. The CEO is Amir H. Nashat. | - |
| Peter Hanson | M | 61 |
eGenesis, Inc.
eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | 4 Jahre |
| Thomas Cahill | M | 37 |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | - |
| Adam Houghton | M | - |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | - |
| Thomas Daniel | M | 70 |
Mozart Therapeutics, Inc.
Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | 4 Jahre |
| Giovanni Magnaghi | M | - |
Axxam SpA
Axxam SpA Miscellaneous Commercial ServicesCommercial Services Axxam SpA provides pharmaceuticals services. The firm specializes in molecular biology, electrophysiology, cellular and biochemical systems. The company was founded by Stefan Lohmer and Alessandro Sidoli in November 2001 and is headquartered in Bresso, Italy. | - |
| Joel C. Barrish | M | - |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Robert A. Millman | M | - |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | - |
| David Steinberg | M | 52 | 3 Jahre | |
| Alastair Riddell | M | 74 | 2 Jahre | |
| Jeffrey Goldberg | M | 51 |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | 2 Jahre |
| Tim Freeborn | M | - | 4 Jahre | |
| Andrew Richards | M | 64 | 3 Jahre | |
| Simon Sturge | M | 65 | 3 Jahre | |
| David J. Ellam | M | - | 3 Jahre | |
| Shaan Gandhi | M | 38 | 2 Jahre | |
| Jia Huey Cheng | F | 48 | 1 Jahre | |
| Cosimo Calcagno | M | - |
Università degli Studi di Napoli Federico II
| 6 Jahre |
| Davide Leonardi | M | 41 |
Università degli Studi di Napoli Federico II
| 7 Jahre |
| Fraser Johnston-Donne | M | - |
University of Cambridge
| 4 Jahre |
| Abinand Rangesh | M | 39 |
University of Cambridge
| 8 Jahre |
| Terese Hougaard | F | - |
University of Cambridge
| 3 Jahre |
| Cristina Escoda | M | - |
University of Cambridge
| 6 Jahre |
| Laura Morrill | F | - |
University of Cambridge
| 4 Jahre |
| Dun Xiao | M | 38 |
University of Cambridge
| 5 Jahre |
| Rosemary Bradley | F | - |
University of Cambridge
| 4 Jahre |
| Wu Lin | M | - |
University of Cambridge
| 4 Jahre |
| Robert Quinn | M | 41 | 4 Jahre | |
| Alexander Katsis | M | - |
University of Cambridge
| 4 Jahre |
| Charles Kok Hoong Chwan | M | - |
University of Cambridge
| 4 Jahre |
| Piotr Krupa | M | - |
University of Cambridge
| 6 Jahre |
| Tim Funnell | M | - |
University of Cambridge
| 3 Jahre |
| Alistair Gray | M | 75 | 9 Jahre | |
| Harry Simpson | M | - |
University of Cambridge
| 4 Jahre |
| Kai Lin | M | - |
University of Cambridge
| 4 Jahre |
| Michael Khan | M | - | 4 Jahre | |
| Lars Guldbæk Karlsson | M | 63 | 1 Jahre | |
| Rahul Vohra | M | - |
University of Cambridge
| 5 Jahre |
| Sanjeet Mangat | F | - |
University of Cambridge
| 2 Jahre |
| Liam Goddard | M | 42 |
University of Cambridge
| 7 Jahre |
| Luca Quagliata | M | - |
Università degli Studi di Napoli Federico II
| 5 Jahre |
| Michael Zhang | M | - |
University of Cambridge
| 4 Jahre |
| Erica Sanchez | F | - |
University of Cambridge
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 63 | 63,00% |
| Vereinigtes Königreich | 29 | 29,00% |
| Italien | 7 | 7,00% |
| Deutschland | 2 | 2,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Lucio Iannone
- Persönliches Netzwerk
